【结 构 式】 |
【分子编号】21131 【品名】1-[(E)-3-bromo-1-propenyl]benzene 【CA登记号】4392-24-9 |
【 分 子 式 】C9H9Br 【 分 子 量 】197.07446 【元素组成】C 54.85% H 4.6% Br 40.55% |
合成路线1
该中间体在本合成路线中的序号:(II)1) Racemic igmesine has been synthesized as follows: Alkylation of 2-phenylbutyric acid (I) with cinnamyl bromide (II) by means of butyllithium in THF gives 2-ethyl-2,5-diphenyl-4-pentenoic acid (III), which is treated with sodium azide and phenyl dichlorophosphate in dichloromethane, yielding the corresponding azide (IV). The Curtius rearrangement of (IV) in refluxing toluene affords the isocyanate (V), which is reduced with LiAlH4/AlCl3 in THF to give N-(1-ethyl-1,4-diphenyl-3-butenyl)-N-metylamine (VI). The acylation of (VI) with cyclopropanecarbonyl chloride (VII) by means of triethylamine in dichloromethane yields the corresponding amide (VIII), which is finally reduced with LiAlH4/AlCl3 in THF/ethyl ether.
【1】
Sorbera, L.A.; Castaner, J.; Silvestre, J.S.; Igmesine Hydrochloride |
【2】 Aubard, G.; Calvet, A.; Gouret, C.; Grouhel, A.; Jacobelli, H.; Junien, J.-L. (Jouveinal SA); Disubstituted benzylamines, process for their preparation, their use as medicament and their synthesis intermediates. EP 0361990; EP 0362001; FR 2636625; US 5034419; US 5089639 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 21130 | 2-Phenylbutyric acid; alpha-Ethylbenzeneacetic acid | 90-27-7 | C10H12O2 | 详情 | 详情 |
(II) | 21131 | 1-[(E)-3-bromo-1-propenyl]benzene | 4392-24-9 | C9H9Br | 详情 | 详情 |
(III) | 21132 | (E)-2-ethyl-2,5-diphenyl-4-pentenoic acid | C19H20O2 | 详情 | 详情 | |
(IV) | 21133 | (E)-2-ethyl-2,5-diphenyl-4-pentenoyl azide | C19H19N3O | 详情 | 详情 | |
(V) | 21134 | 1-[(E)-1-ethyl-1-isocyanato-4-phenyl-3-butenyl]benzene; (E)-1-ethyl-1,4-diphenyl-3-butenyl isocyanate | C19H19NO | 详情 | 详情 | |
(VI) | 21135 | (rac)-[(E)-N-methyl-3,6-diphenyl-5-hexen-3-amine]; (rac)-[N-[(E)-1-ethyl-1,4-diphenyl-3-butenyl]-N-methylamine] | C19H23N | 详情 | 详情 | |
(VII) | 14061 | Cyclopropanecarbonyl chloride; Cyclopropanecarboxylic acid chloride | 4023-34-1 | C4H5ClO | 详情 | 详情 |
(VIII) | 21137 | (rac)-[N-[(E)-1-ethyl-1,4-diphenyl-3-butenyl]-N-methylcyclopropanecarboxamide] | C23H27NO | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(II)Synthesis of intermediate triphenylphosphonium salt (VII): The condensation of the chiral oxazolidinone (I) with cinnamyl bromide (II) by means of NaHMDS in THF gives the adduct (III), which is treated with LiBH4 in Et2O/water to yield the alcohol (IV). The protection of (IV) with Tbdms-Cl and imidazole in DMF affords the silyl ether (V), which is treated with ozone and reduced with NaBH4 to provide the alcohol (VI). The reaction of (VI) with I2 and PPh3 gives the desired triphenylphosphonium iodide (VII).
【1】 Mulzer, J.; et al.; A novel highly stereoselective total synthesis of epothilone B and of its (12R,13R) acetonide. Tetrahedron Lett 2000, 41, 40, 7635. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 46163 | (4R,5S)-4-methyl-5-phenyl-3-propionyl-1,3-oxazolidin-2-one | C13H15NO3 | 详情 | 详情 | |
(II) | 21131 | 1-[(E)-3-bromo-1-propenyl]benzene | 4392-24-9 | C9H9Br | 详情 | 详情 |
(III) | 46164 | (4R,5S)-4-methyl-3-[(2S,4E)-2-methyl-5-phenyl-4-pentenoyl]-5-phenyl-1,3-oxazolidin-2-one | C22H23NO3 | 详情 | 详情 | |
(IV) | 46165 | (2S,4E)-2-methyl-5-phenyl-4-penten-1-ol | C12H16O | 详情 | 详情 | |
(V) | 46166 | tert-butyl(dimethyl)silyl (2S,4E)-2-methyl-5-phenyl-4-pentenyl ether; tert-butyl(dimethyl)[[(2S,4E)-2-methyl-5-phenyl-4-pentenyl]oxy]silane | C18H30OSi | 详情 | 详情 | |
(VI) | 46167 | (3S)-4-[[tert-butyl(dimethyl)silyl]oxy]-3-methyl-1-butanol | C11H26O2Si | 详情 | 详情 | |
(VII) | 46168 | ((3S)-4-[[tert-butyl(dimethyl)silyl]oxy]-3-methylbutyl)(triphenyl)phosphonium iodide | C29H40IOPSi | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(V)(R)-2-Bromo-4-methylpentanoic acid (I) was protected as the benzyl ester (II) and subsequently condensed with benzyl tert-butyl malonate (III) in the presence of potassium tert-butoxide to furnish the triester (IV) as an epimeric mixture. Alkylation of (IV) with cinnamyl bromide (V) produced adduct (VI). The key intermediate (VII) was then obtained by catalytic hydrogenation of the benzyl esters and olefin double bond of (VI), followed by thermal malonate decarboxylation.
【1】 Fujisawa, T.; Odake, S.; Morita, Y.; Hongo, T.; Ito, H.; Yasuda, J.; Suda, E.; Igeta, K.; Morikawa, T. (Fuji Yakuhin Kogyo Co., Ltd.); Highly water-soluble metalloproteinase inhibitor. EP 0832875; WO 9633968 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 26058 | (2S)-2-bromo-4-methylpentanoic acid | C6H11BrO2 | 详情 | 详情 | |
(II) | 60695 | benzyl (2R)-2-bromo-4-methylpentanoate | C13H17BrO2 | 详情 | 详情 | |
(III) | 60696 | 1-benzyl 3-(tert-butyl) malonate | C14H18O4 | 详情 | 详情 | |
(IV) | 60697 | 1,2-dibenzyl 1-(tert-butyl) (2R)-4-methyl-1,1,2-pentanetricarboxylate | C27H34O6 | 详情 | 详情 | |
(V) | 21131 | 1-[(E)-3-bromo-1-propenyl]benzene | 4392-24-9 | C9H9Br | 详情 | 详情 |
(VI) | 60698 | 4,5-dibenzyl 4-(tert-butyl) (E,5R)-7-methyl-1-phenyl-1-octene-4,4,5-tricarboxylate | C36H42O6 | 详情 | 详情 | |
(VII) | 60699 | (2R)-3-(tert-butoxycarbonyl)-2-isobutyl-6-phenylhexanoic acid | C21H32O4 | 详情 | 详情 |
合成路线4
该中间体在本合成路线中的序号:(II)Alkylation of 14-hydroxycodeinone (I) with cinnamyl bromide (II) in the presence of NaH in DMF gives 14-cinnamyloxycodeinone (III). Catalytic hydrogenation of (III) over Pd/C catalyst affords the corresponding 7,8-dihydro-14-phenylpropoxy derivative (IV). N-Demethylation of (IV) is accomplished by treatment with 1-chloroethyl chloroformate, followed by cleavage of the intermediate chloroethyl carbamate in refluxing MeOH. The resulting N-nor derivative (V) is then alkylated with allyl bromide (VI) using K2CO3 in DMF to provide the N-allyl amine (VII). O-Demethylation of (VII) with boiling 48% HBr yields phenol (VIII). Finally, catalytic hydrogenation of the N-allyl group of (VIII) in the presence of Pd/C affords the title N-propyl derivative.
【1】 Greiner, E.; Spetea, M.; Krassnig, R.; Schullner, F.; Aceto, M.; Harris, L.S.; Traynor, J.R.; Woods, J.H.; Coop, A.; Schmidhammer, H.; Synthesis and biological evaluation of 14-alkoxymorphinans. 18.(1) N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: Extending the scope of common structure-activity relationships. J Med Chem 2003, 46, 9, 1758. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 64962 | 17-hydroxy-4-methyl-10-(methyloxy)-12-oxa-4-azapentacyclo[9.6.1.0~1,13~.0~5,17~.0~7,18~]octadeca-7(18),8,10,15-tetraen-14-one | C18H19NO4 | 详情 | 详情 | |
(II) | 21131 | 1-[(E)-3-bromo-1-propenyl]benzene | 4392-24-9 | C9H9Br | 详情 | 详情 |
(III) | 64963 | C27H27NO4 | 详情 | 详情 | ||
(IV) | 64964 | C27H31NO4 | 详情 | 详情 | ||
(V) | 64965 | C26H29NO4 | 详情 | 详情 | ||
(VI) | 11463 | 3-Bromo-1-propene; 3-Bromopropene;allyl bromide | 106-95-6 | C3H5Br | 详情 | 详情 |
(VII) | 64966 | C29H33NO4 | 详情 | 详情 | ||
(VIII) | 64967 | C28H31NO4 | 详情 | 详情 |